DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Hanania NA, Korenblat P, Chapman KR. , et al.
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.
Lancet Respir Med 2016;
4 (10) 781-796
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.